Skip to content
Oxcia

Oxcia

  • About us
    • About us
    • Management
    • Board
    • Scientific Advisory Board
    • Collaborators
    • Partnerships
    • History
    • Careers
  • Scientific Platform
    • Scientific Platform
    • Glossary
  • Pipeline
    • Pipeline
    • OXC-101
    • OXC-201
  • Investors
    • Investors
    • Governance
    • Ownership structure
    • Financial reports
    • Presentations
    • Upcoming events
    • Investor contact
  • Investerare
    • Investerare
    • Bolagsstyrning
    • Bolagsstämma
    • Ägarstruktur
    • Finansiella rapporter
    • Pressmeddelanden
    • Presentationer
    • Kalender
    • Investerarkontakt
  • News and Press
  • Contact
  • Search

Home › News and Press › Page 5

News and Press releases

View all News Press releases

Large interest in OXC-201 at the IPF Summit in Boston

September 2, 2022 · News and Press
Read article

Oxcia attending IPF Summit in Boston

August 24, 2022 · News and Press
Read article

Chief financial officer (deltid)

June 14, 2022 · News and Press
Read article

Translational Scientist/Director to Oxcia AB

May 2, 2022 · News and Press
Read article

Arctic Securities Biotech Webinar 26th April 2022

· News and Press
Read article

New studies show OXC-101 further improves conventional chemotherapy treatment in Acute Myelom Leukemia (AML)

March 23, 2022 · News and Press
Read article

Oxcia reports positive interim data from clinical phase I study in advanced solid cancers

January 17, 2022 · News and Press
Read article

Oxcia contracts Patheon for manufacturing and further strengthens the organization

· News and Press
Read article

Affärsjurist till Oxcia AB

September 22, 2021 · News and Press
Read article

New studies show potential role for Karonudib also in autoimmune diseases

September 7, 2021 · News and Press
Read article

Oxcia employs a Chief Medical Officer (CMO)

August 23, 2021 · News and Press
Read article

Kommunike från årsstämma

July 13, 2021 · News and Press
Read article
« Back 1 … 3 4 5 6 Forward »

Contact us

Oxcia AB
Norrbackagatan 70C
113 34 Stockholm, Sweden

+46 (0)73 270 96 05

info@oxcia.com

Privacy policy

Menu

  • About us
    • About us
    • Management
    • Board
    • Scientific Advisory Board
    • Collaborators
    • Partnerships
    • History
    • Careers
  • Scientific Platform
    • Scientific Platform
    • Glossary
  • Pipeline
    • Pipeline
    • OXC-101
    • OXC-201
  • Investors
    • Investors
    • Governance
    • Ownership structure
    • Financial reports
    • Presentations
    • Upcoming events
    • Investor contact
  • Investerare
    • Investerare
    • Bolagsstyrning
    • Bolagsstämma
    • Ägarstruktur
    • Finansiella rapporter
    • Pressmeddelanden
    • Presentationer
    • Kalender
    • Investerarkontakt
  • News and Press
  • Contact
  • Search

Social media

  • Linkedin

OXC-201

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council. Neither the European Union nor the European Innovation Council can be held responsible for them.


an EIC project aiming to bring hope to IPF patients

© Copyright Oxcia 2025 · Legal Notice · Information About Cookies

Search

More results

Generic filters